53461 5-Year Risk of Skin Cancer in Inflammatory Bowel Disease Patients treated with Vedolizumab versus Tumor Necrosis Factor-α Antagonists

Autor: Camacho, Isabella, Pakhchanian, Haig, Raiker, Rahul, Crow, Lauren, Pugliano-Mauro, Melissa
Zdroj: In Journal of the American Academy of Dermatology September 2024 91(3) Supplement:AB100-AB100
Databáze: ScienceDirect